Volume 16, Number 8—August 2010
CME ACTIVITY - Research
Correlation of Pandemic (H1N1) 2009 Viral Load with Disease Severity and Prolonged Viral Shedding in Children
Table 3
Characteristics of 60 patients who were infected with pandemic (H1N1) 2009 virus, by age group, Taiwan*
Characteristic | No. (%) patients |
p value† | |
---|---|---|---|
Age <13 years, n = 31 | Age >13 years, n = 29 | ||
Sex, M/F |
14/17 |
15/14 |
0.611 |
Disease severity | |||
URI/bronchitis | 22 (71.0) | 22 (75.9) | 0.859‡ |
Pneumonia | 9 (29.0) | 5 (17.2) | |
Meningoencephalitis |
0 |
2 (6.9) |
|
Duration of fever after antiviral treatment, h | |||
<24 | 23 (74.2) | 26 (89.7) | 0.122§ |
24–48 | 5 (16.1) | 2 (6.9) | |
>48 |
3 (9.7) |
1 (3.4) |
|
Time to initiate antiviral treatment, h | |||
<48 | 25 (80.6) | 24 (82.8) | 0.833 |
>48 |
6 (19.4) |
5 (17.2) |
|
Viral load from the first throat swab, log10 copies/mL | |||
<4.35 | 16 (51.6) | 14 (48.3) | 0.796 |
>4.35 |
15 (48.4) |
15 (51.7) |
|
Coexisting condition | |||
Any 1 condition | 8 (25.8) | 6 (20.7) | 0.640 |
Asthma | 7 | 0 | |
Ventricular septal defect | 1 | 0 | |
Hypertension | 0 | 5 | |
Cerebrovascular disease | 0 | 1 | |
Congestive heart failure | 0 | 1 | |
Diabetes | 0 | 1 | |
Pregnancy | 0 | 1 |
*URI, upper respiratory tract infection.
†p values were calculated by χ2 test.
‡The URI/bronchitis group was compared with the combined group of pneumonia and meningoencephalitis.
§Fever lasting <24 h after antiviral treatment vs. fever lasting 24 h or longer after antiviral treatment.